Price $176.94 |
Market Cap
472.42B
|
Sector Health Care |
Div. Growth
5.00%
|
|
P/E
23.9
|
P/B
6.25
|
P/S
4.92
|
Dividend %
2.50%
|
|
P/CF
-
|
P/FCF
55.4
|
Op. Cash Flow
23.32M
|
FCF
3.2
|
|
Op. Margin
22.40%
|
Net Margin
20.90%
|
ROE
27.50%
|
ROI
19.40%
|
|
ROA
11.10%
|
EPS Growth
30.60%
|
Current Ratio
1.3
|
Debt/Equity
40.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.04 | - | - | 30.9M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.59 | - | - | 22.4M | Strong Buy |
| Assertio Holdings Inc (ASRT) | $2.85 | - | - | 136.8M | Strong Buy |
| Cyclo Therapeutics Inc (CYTH) | $2.10 | - | - | 19.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
